Only one position mutation, V6A, introduced to the molecule greatly improved the toxicity profile and decreased VLS as compared to the WT molecule [76]. Additional research and scientific trials are going to be vital to find out if this modified construct has enhanced safety and efficacy in individuals.IL-18 could be A different cytokine linked to